Atkinson Sarah J, Nolan Meghan, Klingbeil Lindsey, Harmon Kelli, Lahni Patrick, Zingarelli Basilia, Wong Hector R
1Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center and Cincinnati Children's Research Foundation, Cincinnati, OH. 2Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH. 3Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.
Crit Care Med. 2016 Apr;44(4):e200-6. doi: 10.1097/CCM.0000000000001374.
Inhibition of matrix metalloproteinase-8 improves survival following cecal ligation and puncture in mice, making it a potential therapeutic target. In the current study, we expand our understanding of the role of matrix metalloproteinase-8 in sepsis by using an adoptive transfer approach and alternative sepsis models.
We used three different sepsis models: cecal ligation and puncture, cecal slurry, and intestinal implantation. In our first model, adoptive transfer experiments were followed by cecal ligation and puncture to test the hypothesis that matrix metalloproteinase-8-containing myeloid cells are a critical factor in sepsis following cecal ligation and puncture. Our second model, cecal slurry, used intraperitoneal injections of cecal contents to induce polymicrobial peritonitis without tissue compromise in the recipient. Our third model, intestinal implantation, involved ligating and puncturing a cecum from a donor, and then removing the cecum and placing it into the recipient's peritoneal cavity. Clinically, blood samples were drawn from pediatric patients within 24 hours of meeting criteria for septic shock.
Basic science laboratory.
Wild type and genetically modified mice.
Experimental models of sepsis.
In our adoptive transfer experiments, matrix metalloproteinase-8 null mice receiving wild-type marrow had a survival advantage when compared with wild-type mice receiving matrix metalloproteinase-8 null marrow, suggesting that matrix metalloproteinase-8-containing myeloid cells are not a critical factor in sepsis following cecal ligation and puncture. In our cecal slurry model, no survival advantage was seen among matrix metalloproteinase-8 null mice. Our third model, intestinal implantation, found that mice receiving matrix metalloproteinase-8 null intestine had a survival advantage when compared with mice receiving wild-type intestine, regardless of recipient genotype. Clinically, median matrix metalloproteinase-8 serum concentrations were higher in patients with sepsis and primary intestinal pathology than in septic patients without primary intestinal pathology.
Intestine-derived matrix metalloproteinase-8 is a critical component of septic peritonitis secondary to intestinal compromise.
抑制基质金属蛋白酶-8可提高小鼠盲肠结扎穿孔术后的存活率,使其成为一个潜在的治疗靶点。在本研究中,我们通过采用过继转移方法和其他脓毒症模型,扩展了对基质金属蛋白酶-8在脓毒症中作用的理解。
我们使用了三种不同的脓毒症模型:盲肠结扎穿孔、盲肠灌洗液和肠植入。在我们的第一个模型中,过继转移实验后进行盲肠结扎穿孔,以检验含有基质金属蛋白酶-8的髓样细胞是盲肠结扎穿孔后脓毒症关键因素这一假设。我们的第二个模型,盲肠灌洗液,采用腹腔注射盲肠内容物来诱导多微生物性腹膜炎,而不损伤受体组织。我们的第三个模型,肠植入,包括结扎和穿刺供体的盲肠,然后取出盲肠并将其放入受体的腹腔。临床上,在符合感染性休克标准的24小时内从小儿患者中采集血样。
基础科学实验室。
野生型和基因改造小鼠。
脓毒症实验模型。
在我们的过继转移实验中,与接受基质金属蛋白酶-8基因敲除骨髓的野生型小鼠相比,接受野生型骨髓的基质金属蛋白酶-8基因敲除小鼠具有生存优势,这表明含有基质金属蛋白酶-8的髓样细胞不是盲肠结扎穿孔后脓毒症的关键因素。在我们的盲肠灌洗液模型中,基质金属蛋白酶-8基因敲除小鼠未显示出生存优势。我们的第三个模型,肠植入,发现无论受体基因型如何,接受基质金属蛋白酶-8基因敲除肠的小鼠与接受野生型肠的小鼠相比具有生存优势。临床上,患有脓毒症和原发性肠道病变的患者血清基质金属蛋白酶-8中位数浓度高于无原发性肠道病变的脓毒症患者。
肠道来源的基质金属蛋白酶-8是肠道损伤继发感染性腹膜炎的关键组成部分。